Iberis Capital
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
